Taylor Stevens

• Select Medical Holdings Corporation, a leading operator of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers, and Concentra Group Holdings Parent, Inc., a wholly owned subsidiary of Select Medical, in connection with Concentra’s IPO.
• Sound Point Meridian Capital, Inc., a registered closed-end fund, in its US$80 million initial public offering of common stock.
• Sempra Energy in a series of preferred stock and convertible notes offerings aggregating over US$1 billion.
• Solo Brands, Inc. in its initial public offering on the New York Stock Exchange.
• Science 37, Inc. in its de-SPAC merger with LifeSci Acquisition II Corp., a Nasdaq-listed blank check company.
• Merus N.V., a Netherlands-based clinical-stage oncology company, in its U.S. IPO on Nasdaq.
• A United States-based chain of retail toy stores in an exchange offer for certain of its outstanding Senior Notes, subsequent follow-on issuance of notes, and series of global corporate restructuring transactions.
• The underwriters in the initial public offering of Sweetgreen, Inc. on the New York Stock Exchange.
• The underwriters in the initial public offering of Dutch Bros Inc. on the New York Stock Exchange.
• The underwriters in a registered public offering by Gilead Sciences of US$7.25 billion of senior unsecured notes.
• The initial purchasers in the offering by Tronox Holdings plc of US$500 million of senior secured notes.
• The initial purchasers in connection with the sale of US$1 billion of senior notes by a Kazakhstan-based oil company as part of a multi-component project financing including a bank loan facility and private loans.

Includes matters handled at Dechert or prior to joining the firm.